{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:23:05Z","timestamp":1792516985298,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Among the unmet needs in psoriatic arthritis (PsA), the precise mechanisms underlying the contribution of genetic susceptibility, environmental triggers and systemic inflammation are still under investigation. As a complex and multi-factorial condition, metabolomics in PsA may offer additional insight into pathways driving the pathogenesis, allowing for a better understanding of the disease-related variations downstream of the genome and proteome. In this study, the serum metabolomics profile of PsA was compared with healthy controls, by nuclear magnetic resonance spectroscopy (\n                    <jats:sup>1<\/jats:sup>\n                    H-NMR). Twenty-nine PsA patients according to CASPAR criteria and DAPSA\u2009&gt;\u200914 score plus 33 healthy controls matched for mean age and gender ratio, were enrolled. The sera metabolomics profile was analysed with a Varian Unity Inova 500\u00a0MHz NMR spectrometer, combined with multivariate statistical analysis (MVA). The MetaboAnalyst program was used to generate ROC curves and to perform the enrichment analysis. The OPLS-DA models exhibited a clear separation between the two groups, and the metabolomic profile of PsA patients was characterized by a significant increase in glucose and glycyl proline, and a significant decrease in alanine, glutamine, methionine, serine and the branched-chain amino acids leucine, isoleucine and valine. The ROC curve was 0.842 (95% CI 0.735\u20130.949), and a significant direct correlation of alanine and leucine levels with the DAPSA score was recorded. Finally, the enrichment analysis unveiled that in PsA patients, the most enriched pathways were glucose-alanine cycle, glycine and serine, glutathione, selenoamino acid, alanine and tryptophan metabolism, with a close relationship between pathways. The metabolomic profiling in PsA may offer additional insight to elucidate the metabolite unbalance on inflammatory burden, oxidative stress, energy and collagen metabolism, but also on peculiar features of the disease, such as metabolic disorders and diabetes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-34101-4","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:04:04Z","timestamp":1767071044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways"],"prefix":"10.1038","volume":"16","author":[{"given":"M. M.","family":"Angioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. P.","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Floris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lilliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Congia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"10","key":"34101_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N Engl. J. Med. 376 (10), 957\u2013970 (2017).","journal-title":"N Engl. J. Med."},{"key":"34101_CR2","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","volume":"214","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada, L. M. & Merola, J. F. Comorbidities associated with psoriatic arthritis: review and update. Clin. Immunol. 214, 108397 (2020).","journal-title":"Clin. Immunol."},{"key":"34101_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","volume":"42","author":"NJ McHugh","year":"2003","unstructured":"McHugh, N. J., Balachrishnan, C. & Jones, S. M. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatol. (Oxford). 42, 778\u2013783 (2003).","journal-title":"Rheumatol. (Oxford)"},{"issue":"723944","key":"34101_CR4","first-page":"18","volume":"8","author":"SR Pennington","year":"2021","unstructured":"Pennington, S. R. & FitzGerald, O. Early origins of psoriatic arthritis: Clinical, genetic and molecular biomarkers of progression from psoriasis to psoriatic arthritis. Front. Med. (Lausanne). 8 (723944), 18 (2021).","journal-title":"Front. Med. (Lausanne)"},{"key":"34101_CR5","doi-asserted-by":"publisher","first-page":"1054539","DOI":"10.3389\/fimmu.2022.1054539","volume":"30","author":"T Wirth","year":"2022","unstructured":"Wirth, T., Balandraud, N., Boyer, L., Lafforgue, P. & Pham, T. Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. Front. Immunol. 30, 13:1054539 (2022).","journal-title":"Front. Immunol."},{"key":"34101_CR6","doi-asserted-by":"publisher","first-page":"108318","DOI":"10.1016\/j.clim.2019.108318","volume":"211","author":"J Pouw","year":"2020","unstructured":"Pouw, J., Leijten, E., Radstake, T. & Boes, M. Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature. Clin. Immunol. 211, 108318 (2020).","journal-title":"Clin. Immunol."},{"key":"34101_CR7","doi-asserted-by":"publisher","first-page":"1274539","DOI":"10.3389\/fimmu.2023.1274539","volume":"14","author":"MM Angioni","year":"2023","unstructured":"Angioni, M. M. et al. Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study. Front. Immunol. 14, 1274539 (2023).","journal-title":"Front. Immunol."},{"key":"34101_CR8","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.3390\/jcm12186090","volume":"12","author":"A Floris","year":"2023","unstructured":"Floris, A. et al. The challenging differentiation of psoriatic arthritis from other arthropathies and nonspecific arthralgias in patients with psoriasis: results of a Cross-Sectional rheumatologic assessment of a large dermatologic cohort. J. Clin. Med. 12, 6090 (2023).","journal-title":"J. Clin. Med."},{"key":"34101_CR9","doi-asserted-by":"publisher","first-page":"689984","DOI":"10.3389\/fgene.2021.689984","volume":"12","author":"A Floris","year":"2021","unstructured":"Floris, A. et al. Targeted therapies in axial psoriatic arthritis. Front. Genet. 12, 689984 (2021).","journal-title":"Front. Genet."},{"key":"34101_CR10","doi-asserted-by":"publisher","first-page":"101694","DOI":"10.1016\/j.berh.2021.101694","volume":"35","author":"C Stober","year":"2021","unstructured":"Stober, C. Pathogenesis of psoriatic arthritis. Best Pract. Res. Clin. Rheumatol. 35, 101694 (2021).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"34101_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/ar2580","volume":"11","author":"O Fitzgerald","year":"2009","unstructured":"Fitzgerald, O. & Winchester, R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res. Ther. 11, 214 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"34101_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J. E., Chan, T. C. & Krueger, J. G. Psoriasis pathogenesis and the development of novel targeted immune therapies. J. Allergy Clin. Immunol. 140, 645\u2013653 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34101_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.46497\/ArchRheumatol.2024.10710","volume":"39","author":"C Lopez-Medina","year":"2024","unstructured":"Lopez-Medina, C., Kalyoncu, U. & Gossec, L. Unmet needs in psoriatic arthritis, a narrative review. Arch. Rheumatol. 39, 159\u2013171 (2024).","journal-title":"Arch. Rheumatol."},{"key":"34101_CR14","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.3390\/ijms24054901","volume":"24","author":"AB Azuaga","year":"2023","unstructured":"Azuaga, A. B., Ram\u00edrez, J. & Ca\u00f1ete, J. D. Psoriatic arthritis: pathogenesis and targeted therapies. Int. J. Mol. Sci. 24, 4901 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"34101_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40744-020-00229-0","volume":"7","author":"E Lubrano","year":"2020","unstructured":"Lubrano, E. et al. Impact of comorbidities on disease Activity, patient global Assessment, and function in psoriatic arthritis: A Cross-Sectional study. Rheumatol. Ther. 7, 825\u2013836 (2020).","journal-title":"Rheumatol. Ther."},{"key":"34101_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/OARRR.S347797","volume":"14","author":"R Aljohani","year":"2022","unstructured":"Aljohani, R. Metabolic syndrome and its components in psoriatic arthritis. Open. Access. Rheumatol. 14, 7\u201316 (2022).","journal-title":"Open. Access. Rheumatol."},{"key":"34101_CR17","first-page":"310","volume":"6","author":"M Ghasemi","year":"2016","unstructured":"Ghasemi, M. et al. Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis. Am. J. Nucl. Med. Mol. Imaging. 6, 310\u2013327 (2016).","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"34101_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/14737159.2018.1481391","volume":"18","author":"\u00c1 L\u00f3pez-L\u00f3pez","year":"2018","unstructured":"L\u00f3pez-L\u00f3pez, \u00c1., L\u00f3pez-Gonz\u00e1lvez, \u00c1., Barker-Tejeda, T. C. & Barbas, C. A review of validated biomarkers obtained through metabolomics. Expert Rev. Mol. Diagn. 18, 557\u2013575 (2018).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"34101_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11306-016-1108-4","volume":"12","author":"DB Kell","year":"2016","unstructured":"Kell, D. B. & Oliver, S. G. The metabolome 18 years on: a concept comes of age. Metabolomics 12, 148 (2016).","journal-title":"Metabolomics"},{"key":"34101_CR20","doi-asserted-by":"publisher","first-page":"102949","DOI":"10.1016\/j.autrev.2021.102949","volume":"20","author":"A Grivas","year":"2021","unstructured":"Grivas, A. et al. Unraveling the complexities of psoriatic arthritis by the use of -Omics and their relevance for clinical care. Autoimmun. Rev. 20, 102949 (2021).","journal-title":"Autoimmun. Rev."},{"key":"34101_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.12688\/f1000research.4709.1","volume":"3","author":"AW Armstrong","year":"2014","unstructured":"Armstrong, A. W. et al. Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res 3, 248 (2014).","journal-title":"F1000Res"},{"issue":"2","key":"34101_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jdermsci.2021.03.006","volume":"102","author":"T Kishikawa","year":"2021","unstructured":"Kishikawa, T. et al. Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes. J. Dermatol. Sci. 102 (2), 78\u201384 (2021).","journal-title":"J. Dermatol. Sci."},{"key":"34101_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","volume":"79","author":"M Souto-Carneiro","year":"2020","unstructured":"Souto-Carneiro, M. et al. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis. Ann. Rheum. Dis. 79, 499\u2013506 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"34101_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/annrheumdis-2021-220168","volume":"80","author":"K Colaco","year":"2021","unstructured":"Colaco, K. et al. Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Ann. Rheum. Dis. 80, 1429\u20131435 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"34101_CR25","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.3390\/ijms22147389","volume":"22","author":"K Bogunia-Kubik","year":"2021","unstructured":"Bogunia-Kubik, K. et al. Disease differentiation and monitoring of Anti-TNF treatment in rheumatoid arthritis and spondyloarthropathies. Int. J. Mol. Sci. 22, 7389 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"34101_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/jpm12060924","volume":"12","author":"E Dorochow","year":"2022","unstructured":"Dorochow, E., K\u00f6hm, M., Hahnefeld, L. & Gurke, R. Metabolic profiling in rheumatoid Arthritis, psoriatic Arthritis, and psoriasis: elucidating Pathogenesis, improving Diagnosis, and monitoring disease activity. J. Pers. Med. 12, 924 (2022).","journal-title":"J. Pers. Med."},{"key":"34101_CR27","first-page":"481","volume":"37","author":"R Coras","year":"2019","unstructured":"Coras, R. et al. Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis. Clin. Exp. Rheumatol. 37, 481\u2013484 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"34101_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11306-019-1527-0","volume":"15","author":"R Coras","year":"2019","unstructured":"Coras, R. et al. Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics 15, 65 (2019).","journal-title":"Metabolomics"},{"key":"34101_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11306-023-02079-7","volume":"20","author":"J Koussiouris","year":"2024","unstructured":"Koussiouris, J. et al. Classifying patients with psoriatic arthritis according to their disease activity status using serum metabolites and machine learning. Metabolomics 20, 17 (2024).","journal-title":"Metabolomics"},{"key":"34101_CR30","doi-asserted-by":"publisher","first-page":"15299","DOI":"10.3390\/ijms242015299","volume":"24","author":"H Choksi","year":"2023","unstructured":"Choksi, H. et al. Identifying serum metabolomic markers associated with skin disease activity in patients with psoriatic arthritis. Int. J. Mol. Sci. 24, 15299 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"34101_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3899\/jrheum.110845","volume":"39","author":"W Tillett","year":"2012","unstructured":"Tillett, W. et al. The classification for psoriatic arthritis (CASPAR) criteria\u2013a retrospective feasibility, sensitivity, and specificity study. J. Rheumatol. 39, 154\u2013156 (2012).","journal-title":"J. Rheumatol."},{"issue":"Suppl 11","key":"34101_CR32","first-page":"S64","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease, P. J. Measures of psoriatic arthritis: tender and swollen joint assessment, psoriasis area and severity index (PASI), nail psoriasis severity index (NAPSI), modified nail psoriasis severity index (mNAPSI), Mander\/Newcastle enthesitis index (MEI), Leeds enthesitis index (LEI), spondyloarthritis research consortium of Canada (SPARCC), Maastricht ankylosing spondylitis enthesis score (MASES), Leeds dactylitis index (LDI), patient global for psoriatic arthritis, dermatology life quality index (DLQI), psoriatic arthritis quality of life (PsAQOL), functional assessment of chronic illness Therapy-Fatigue (FACIT-F), psoriatic arthritis response criteria (PsARC), psoriatic arthritis joint activity index (PsAJAI), disease activity in psoriatic arthritis (DAPSA), and composite psoriatic disease activity index (CPDAI). Arthrit. Care Res. (Hoboken) 63 (Suppl 11), S64\u201385 (2011).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"34101_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957). PMID: 13428781.","journal-title":"J. Biol. Chem."},{"key":"34101_CR34","doi-asserted-by":"publisher","first-page":"20418","DOI":"10.1038\/s41598-020-76876-8","volume":"10","author":"C Piras","year":"2020","unstructured":"Piras, C. et al. Metabolomics and psychological features in fibromyalgia and electromagnetic sensitivity. Sci. Rep. 10, 20418 (2020).","journal-title":"Sci. Rep."},{"key":"34101_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA van den Berg","year":"2006","unstructured":"van den Berg, R. A. et al. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genom. 7, 142 (2006).","journal-title":"BMC Genom."},{"key":"34101_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jspi.2019.06.001","volume":"205","author":"X Chen","year":"2020","unstructured":"Chen, X. & Sarkar, S. K. On Benjamini\u2013Hochberg procedure applied to mid p-values. J. Stat. Plan. Inference. 205, 34\u201345 (2020).","journal-title":"J. Stat. Plan. Inference"},{"key":"34101_CR37","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/ac060209g","volume":"78","author":"AM Weljie","year":"2006","unstructured":"Weljie, A. M., Newton, J., Mercier, P., Carlson, E. & Slupsky, C. M. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78, 4430\u20134442 (2006).","journal-title":"Anal. Chem."},{"key":"34101_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcb.26174","volume":"119","author":"MSH Akash","year":"2018","unstructured":"Akash, M. S. H., Rehman, K. & Liaqat, A. Tumor necrosis Factor-Alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J. Cell. Biochem. 119, 105\u2013110 (2018).","journal-title":"J. Cell. Biochem."},{"key":"34101_CR39","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1074\/jbc.M101521200","volume":"277","author":"V Aguirre","year":"2002","unstructured":"Aguirre, V. et al. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277, 1531\u20131537 (2002).","journal-title":"J. Biol. Chem."},{"key":"34101_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00726-008-0051-8","volume":"35","author":"A Surazynski","year":"2008","unstructured":"Surazynski, A., Miltyk, W., Palka, J. & Phang, J. M. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids. 35, 731\u2013738 (2008).","journal-title":"Amino Acids"},{"key":"34101_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF01366930","volume":"17","author":"J Le","year":"1999","unstructured":"Le, J. et al. Urine glycyl-L-proline increase and skin trophicity. Amino Acids. 17, 315\u2013322 (1999).","journal-title":"Amino Acids"},{"key":"34101_CR42","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1177\/0961203311418707","volume":"20","author":"X Ouyang","year":"2011","unstructured":"Ouyang, X., Dai, Y., Wen, J. L. & Wang, L. X. \u00b9H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus 20, 1411\u20131420 (2011).","journal-title":"Lupus"},{"key":"34101_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jcp.1041430112","volume":"143","author":"B Koch","year":"1990","unstructured":"Koch, B., Schr\u00f6der, M. T., Sch\u00e4fer, G. & Schauder, P. Comparison between transport and degradation of leucine and glutamine by peripheral human lymphocytes exposed to Concanavalin A. J. Cell. Physiol. 143, 94\u201399 (1990).","journal-title":"J. Cell. Physiol."},{"key":"34101_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cbf.1109","volume":"22","author":"TC Pithon-Curi","year":"2004","unstructured":"Pithon-Curi, T. C., De Melo, M. P. & Curi, R. Glucose and glutamine utilization by rat lymphocytes, monocytes and neutrophils in culture: a comparative study. Cell. Biochem. Funct. 22, 321\u2013326 (2004).","journal-title":"Cell. Biochem. Funct."},{"key":"34101_CR45","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7150\/thno.51154","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis. Theranostics 11, 754\u2013767 (2021).","journal-title":"Theranostics"},{"key":"34101_CR46","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/ar3243","volume":"13","author":"RK Madsen","year":"2011","unstructured":"Madsen, R. K. et al. Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res. Ther. 13, R19 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"34101_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1523-1747.ep12611394","volume":"99","author":"WT Schroeder","year":"1992","unstructured":"Schroeder, W. T. et al. Type I keratinocyte transglutaminase: expression in human skin and psoriasis. J. Invest. Dermatol. 99, 27\u201334 (1992).","journal-title":"J. Invest. Dermatol."},{"key":"34101_CR48","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1021\/pr500782g","volume":"14","author":"MA Kamleh","year":"2015","unstructured":"Kamleh, M. A. et al. LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in Circulating amino acids that are ameliorated by anti-TNF\u03b1 treatment. J. Proteome Res. 14, 557\u2013566 (2015).","journal-title":"J. Proteome Res."},{"key":"34101_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","volume":"15","author":"M Hole\u010dek","year":"2018","unstructured":"Hole\u010dek, M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr. Metab. (Lond). 15, 33 (2018).","journal-title":"Nutr. Metab. (Lond)"},{"key":"34101_CR50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448\u2013453 (2011).","journal-title":"Nat. Med."},{"key":"34101_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40744-020-00206-7","volume":"7","author":"G Dal Bello","year":"2020","unstructured":"Dal Bello, G., Gisondi, P., Idolazzi, L. & Girolomoni, G. Psoriatic arthritis and diabetes mellitus: A narrative review. Rheumatol. Ther. 7, 271\u2013285 (2020).","journal-title":"Rheumatol. Ther."},{"key":"34101_CR52","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.3390\/nu7115486","volume":"7","author":"YC Li","year":"2015","unstructured":"Li, Y. C. et al. The ratio of dietary Branched-Chain amino acids is associated with a lower prevalence of obesity in young Northern Chinese adults: an Internet-Based Cross-Sectional study. Nutrients 7, 9573\u20139589 (2015).","journal-title":"Nutrients"},{"key":"34101_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cmet.2010.08.016","volume":"12","author":"G D\u2019Antona","year":"2010","unstructured":"D\u2019Antona, G. et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell. Metab. 12, 362\u2013372 (2010).","journal-title":"Cell. Metab."},{"key":"34101_CR54","first-page":"130","volume":"18","author":"D Dubey","year":"2019","unstructured":"Dubey, D. et al. NMR-Based serum metabolomics revealed distinctive metabolic patterns in reactive arthritis compared with rheumatoid arthritis. J. Proteome Res. 18, 130\u2013146 (2019).","journal-title":"J. Proteome Res."},{"key":"34101_CR55","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jpba.2015.10.007","volume":"117","author":"A Zabek","year":"2016","unstructured":"Zabek, A. et al. Application of (1)H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis. J. Pharm. Biomed. Anal. 117, 544\u2013550 (2016).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"34101_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/JEnvironPatholToxicolOncol.2021039409","volume":"40","author":"Y Liu","year":"2021","unstructured":"Liu, Y. & Xie, Y. Metabolomics approach to the exploration of amino acids metabolism changes associated with disease progression in a rat model of Adjuvant-Induced arthritis. J. Environ. Pathol. Toxicol. Oncol. 40, 43\u201352 (2021).","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"34101_CR57","doi-asserted-by":"publisher","first-page":"e0132695","DOI":"10.1371\/journal.pone.0132695","volume":"10","author":"XY Yang","year":"2015","unstructured":"Yang, X. Y. et al. Energy metabolism disorder as a contributing factor of rheumatoid arthritis: A comparative proteomic and metabolomic study. PLoS One. 10, e0132695 (2015).","journal-title":"PLoS One"},{"key":"34101_CR58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels, M. M., Aletaha, D., Alasti, F. & Smolen, J. S. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann. Rheum. Dis. 75, 811\u2013818 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"34101_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-018-1655-3","volume":"20","author":"R Narasimhan","year":"2018","unstructured":"Narasimhan, R. et al. Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Res. Ther. 20, 164 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"34101_CR60","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.joca.2023.04.005","volume":"31","author":"ZY Cui","year":"2023","unstructured":"Cui, Z. Y. et al. Causal associations between serum amino acid levels and osteoarthritis: a Mendelian randomization study. Osteoarthr. Cartil. 31, 1121\u20131131 (2023).","journal-title":"Osteoarthr. Cartil."},{"key":"34101_CR61","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s00216-016-9524-x","volume":"408","author":"G Yang","year":"2016","unstructured":"Yang, G. et al. Metabolic analysis of osteoarthritis subchondral bone based on UPLC\/Q-TOF-MS. Anal. Bioanal Chem. 408, 4275\u20134286 (2016).","journal-title":"Anal. Bioanal Chem."},{"key":"34101_CR62","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3346\/jkms.2014.29.9.1199","volume":"29","author":"YJ Ha","year":"2014","unstructured":"Ha, Y. J. et al. Usefulness of serum leucine-rich alpha-2 glycoprotein as a disease activity biomarker in patients with rheumatoid arthritis. J. Korean Med. Sci. 29, 1199\u20131204 (2014).","journal-title":"J. Korean Med. Sci."},{"key":"34101_CR63","doi-asserted-by":"publisher","first-page":"809225","DOI":"10.3389\/fphar.2021.809225","volume":"12","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Research progress on Leucine-Rich Alpha-2 glycoprotein 1: A review. Front. Pharmacol. 12, 809225 (2022).","journal-title":"Front. Pharmacol."},{"key":"34101_CR64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13075-017-1349-2","volume":"19","author":"H Urushima","year":"2017","unstructured":"Urushima, H. et al. Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-\u03b2-Smad2 signaling in na\u00efve helper T cells. Arthritis Res. Ther. 19, 137 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"34101_CR65","doi-asserted-by":"publisher","first-page":"1028994","DOI":"10.3389\/fimmu.2022.1028994","volume":"13","author":"A Sarkar","year":"2022","unstructured":"Sarkar, A. et al. Upregulation of leucine-rich alpha-2 glycoprotein: A key regulator of inflammation and joint fibrosis in patients with severe knee osteoarthritis. Front. Immunol. 13, 1028994 (2022).","journal-title":"Front. Immunol."},{"key":"34101_CR66","doi-asserted-by":"publisher","first-page":"eabm7902","DOI":"10.1126\/sciadv.abm7902","volume":"8","author":"A Cappello","year":"2022","unstructured":"Cappello, A. et al. Extracellular Serine empowers epidermal proliferation and psoriasis-like symptoms. Sci. Adv. 8, eabm7902 (2022).","journal-title":"Sci. Adv."},{"key":"34101_CR67","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jn\/134.3.489","volume":"134","author":"G Wu","year":"2004","unstructured":"Wu, G. et al. Glutathione metabolism and its implications for health. J. Nutr. 134, 489\u2013492 (2004).","journal-title":"J. Nutr."},{"key":"34101_CR68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","volume":"57","author":"DM Townsend","year":"2003","unstructured":"Townsend, D. M., Tew, K. D. & Tapiero, H. The importance of glutathione in human disease. Biomed. Pharmacother. 57, 145\u2013155 (2003).","journal-title":"Biomed. Pharmacother"},{"key":"34101_CR69","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1211\/jpp.58.7.0010","volume":"58","author":"O Firuzi","year":"2006","unstructured":"Firuzi, O. et al. Oxidative stress parameters in different systemic rheumatic diseases. J. Pharm. Pharmacol. 58, 951\u2013957 (2006).","journal-title":"J. Pharm. Pharmacol."},{"key":"34101_CR70","first-page":"467","volume":"160","author":"S Coaccioli","year":"2009","unstructured":"Coaccioli, S. et al. Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasis. Clin. Ter. 160, 467\u2013472 (2009).","journal-title":"Clin. Ter."},{"key":"34101_CR71","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/iub.1084","volume":"64","author":"AS Rahmanto","year":"2012","unstructured":"Rahmanto, A. S. & Davies, M. J. Selenium-containing amino acids as direct and indirect antioxidants. IUBMB Life. 64, 863\u2013871 (2012).","journal-title":"IUBMB Life"},{"key":"34101_CR72","doi-asserted-by":"publisher","first-page":"109776","DOI":"10.1016\/j.jnutbio.2024.109776","volume":"135","author":"L Wahl","year":"2025","unstructured":"Wahl, L. et al. Serum selenium, Selenoprotein P and glutathione peroxidase 3 in rheumatoid, psoriatic, juvenile idiopathic arthritis, and osteoarthritis. J. Nutr. Biochem. 135, 109776 (2025).","journal-title":"J. Nutr. Biochem."},{"key":"34101_CR73","doi-asserted-by":"publisher","first-page":"1257159","DOI":"10.3389\/fimmu.2023.1257159","volume":"14","author":"AA Mangoni","year":"2023","unstructured":"Mangoni, A. A. & Zinellu, A. A systematic review and meta-analysis of the kynurenine pathway of Tryptophan metabolism in rheumatic diseases. Front. Immunol. 14, 1257159 (2023).","journal-title":"Front. Immunol."},{"key":"34101_CR74","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/metabo12090834","volume":"12","author":"M Liu","year":"2022","unstructured":"Liu, M., Nieuwdorp, M., de Vos, W. M. & Rampanelli, E. Microbial Tryptophan metabolism tunes host Immunity, metabolism, and extraintestinal disorders. Metabolites 12, 834 (2022).","journal-title":"Metabolites"},{"key":"34101_CR75","first-page":"450","volume":"37","author":"G Pongratz","year":"2019","unstructured":"Pongratz, G. et al. Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the rheumatoid arthritis MRI score (RAMRIS). Clin. Exp. Rheumatol. 37, 450\u2013457 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"34101_CR76","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ard-2023-224014","volume":"83","author":"D Moulin","year":"2024","unstructured":"Moulin, D. et al. Counteracting Tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis. Ann. Rheum. Dis. 83, 312\u2013323 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"34101_CR77","doi-asserted-by":"publisher","first-page":"587119","DOI":"10.3389\/fimmu.2021.587119","volume":"12","author":"AJ Berlinberg","year":"2021","unstructured":"Berlinberg, A. J. et al. Multi \u2018Omics analysis of intestinal tissue in ankylosing spondylitis identifies alterations in the Tryptophan metabolism pathway. Front. Immunol. 12, 587119 (2021).","journal-title":"Front. Immunol."},{"key":"34101_CR78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","volume":"42","author":"M Modoux","year":"2021","unstructured":"Modoux, M., Rolhion, N., Mani, S. & Sokol, H. Tryptophan metabolism as a Pharmacological target. Trends Pharmacol. Sci. 42, 60\u201373 (2021).","journal-title":"Trends Pharmacol. Sci."},{"key":"34101_CR79","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/metabo12100950","volume":"12","author":"O Athnaiel","year":"2022","unstructured":"Athnaiel, O., Ong, C. & Knezevic, N. N. The role of kynurenine and its metabolites in comorbid chronic pain and depression. Metabolites 12, 950 (2022).","journal-title":"Metabolites"},{"key":"34101_CR80","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3899\/jrheum.130797","volume":"41","author":"E McDonough","year":"2014","unstructured":"McDonough, E. et al. Depression and anxiety in psoriatic disease: prevalence and associated factors. J. Rheumatol. 41, 887\u2013896 (2014).","journal-title":"J. Rheumatol."},{"key":"34101_CR81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-021-02175-2","volume":"18","author":"LM Chen","year":"2021","unstructured":"Chen, L. M. et al. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J. Neuroinflammation. 18, 135 (2021).","journal-title":"J. Neuroinflammation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34101-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34101-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T11:04:52Z","timestamp":1769684692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34101-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34101"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34101-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The study was conducted following the Good Clinical Practice standards and the Helsinki Declaration, and approved by the Ethical Committee of the University of Cagliari (protocol PG\/2018\/16313).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"3985"}}